Disclosures for "Lecanemab in Clinical Practice: Real-World Treatment Outcomes from a Retrospective Neurological Clinic Case Series Review in Early Alzheimer’s Disease "
-
The institution of Dr. Moon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Moon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Moon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Moon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Moon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Moon has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Moon has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Averitas. Dr. Moon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Copic .
-
Ms. Ferrer has nothing to disclose.